Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib effectively treats severe alopecia areata and is safe.

Apremilast did not work for treating severe alopecia areata.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Upadacitinib improved multiple immune-related conditions in one patient.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Apremilast may help treat hair loss in alopecia areata.

Abrocitinib may effectively treat stubborn alopecia universalis.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Some migraine sufferers had no more headaches after getting a hair transplant.

Patients should discuss complementary medicine use with doctors to improve health outcomes.

Both azathioprine and betamethasone treatments help with hair regrowth in alopecia areata, but azathioprine may have fewer side effects.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.